background severe aat deficiency autosomal recessive genetic condition associated increased variable risk chronic obstructive pulmonary disease copd study undertaken assess impact chronic bronchitis pneumonia asthma sex development copd individuals severe aat deficiency methods aat genetic modifier study multicentre cohort study designed study genetic epidemiological determinants copd aat deficiency NUMBER individuals age range years confirmed homozygous serpina1 z mutation included analyses primary outcomes quantitative outcome forced expiratory volume NUMBER s fev1 percentage predicted qualitative outcome severe airflow obstruction fev1 NUMBER predicted results multivariate analysis overall cohort cigarette smoking sex asthma chronic bronchitis pneumonia risk factors reduced fev1 percentage predicted severe airflow obstruction p001 index cases lower fev1 values higher smoking histories reports adult asthma pneumonia asthma age NUMBER cases p001 men lower fev1 percentage predicted women p00001 lowest fev1 values observed men reporting history childhood asthma NUMBER trend severe obstruction men remained index groups examined separately men representing majority individuals airflow obstruction NUMBER chronic bronchitis NUMBER ci NUMBER NUMBER physicians report asthma NUMBER ci NUMBER NUMBER predictors severe airflow obstruction multivariate analysis men women conclusion individuals severe aat deficiency sex asthma chronic bronchitis pneumonia risk factors severe copd addition cigarette smoking results suggest subjects severely deficient aat men individuals symptoms chronic bronchitis past diagnosis asthma pneumonia benefit closer monitoring potentially earlier treatment alpha1 antitrypsin family based NUMBER NUMBER non index pre post bronchodilator non index non index non index